pharmaphorum

JANUARY 8, 2021

According to one analysis, conducted by Global Data, approximately 67% of trial disruptions during the early stages of the pandemic were due to the suspension of enrolment, followed by the delayed start of planned trials at 18.4% How can pharma improve the patient-centricity of its trials during COVID-19 and beyond?

105

105

pharmaphorum

NOVEMBER 23, 2022

But when viewed in isolation, these robust data sets may only provide HTA bodies with a blinkered view of the broader impact of an intervention. Traditionally, HTA submissions leverage significant amounts of data: data about cost, clinical efficacy, benefits, and risks.

52

52

ISPE

FEBRUARY 3, 2023

The more information you provide, the better able the ISPE C&Q CoP Steering Committee will be able to provide actionable data analysis. We intend to also provide analysis as communicated via webinars, blogs, and presentations. Completing this industry benchmarking survey can provide valuable insights for any business. Take Survey!

Communication 96

Communication 96

STAT

OCTOBER 11, 2023

In a note to investors, Barclays analyst Emily Field wrote that the decision affirmed the view that GLP-1 receptor agonists like Ozempic have “therapeutic benefits far beyond their original intended purpose.” Hello, everyone, and how are you this fine, sunny morning? Our choice today is hazelnut creme. ” The U.S.

FDA 107

FDA 107

Pharmaceutical Technology

NOVEMBER 22, 2022

All this, and the latest pharma industry news , comment, data, and analysis from GlobalData. Click here to view the latest issue of Pharmaceutical Technology Focus. Most recently, after a tumultuous 45 days, Liz Truss resigned as the UK’s prime minister paving the way for Rishi Sunak to take on the mantle.

93

93

European Pharmaceutical Review

OCTOBER 13, 2023

Analysis of microbial growth in cultures using fluorescent optical respirometry Study results FOR significantly shortened the time of the studies from three days for bacteria and five days for yeasts to 10 hours and 15 hours, respectively, the authors noted.

100

100

STAT

AUGUST 17, 2023

As a result, the CEOs of more than 300 publicly traded health care companies combined to make $4 billion in 2022, according to a STAT analysis of financial filings. The analysis focused on companies that were worth at least $1 billion in March, based on data from financial database provider AlphaSense.

Nursing Homes 98

Nursing Homes Prescription Filling Insurance Hospitals 98

pharmaphorum

APRIL 30, 2021

A recent analysis delves into the challenges companies face in getting digital health technologies reimbursed and presents recommendations for how they can find a smoother path to market. Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage. Time for a NICE change.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 98

pharmaphorum

OCTOBER 26, 2020

A new analysis looks at these barriers and asks how they could be overcome. Understanding payer views of preventive care. Preventive care programmes are key to better health outcomes, but several factors are limiting their uptake.

Vaccines 129

Vaccines 129

Hospital Pharmacy Europe

SEPTEMBER 4, 2023

The analysis revealed that the severity was associated with higher levels of maternal depression across postpartum years 1.5 In further analysis, the researchers observed postnatal SSRI treatment moderated associations between postnatal depression and maternal depression at postpartum year 1.5

Hospitals 98

Hospitals 98

pharmaphorum

OCTOBER 20, 2022

Historically, competitive and market analysis data has been stored in spreadsheets. Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that spans teams, functions, and geographies.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Data Entry Documentation 98

ISPE

JUNE 26, 2023

Nevertheless, digitization is not an end in itself and must not be viewed in isolation. Overall, this can also lead to a harmonization of the way we view digitization as a business process. Regulators and Industry Discuss Digital Transformation and Pharma 4.0™ Regulators and Industry Discuss Digital Transformation and Pharma 4.0™

FDA 97

FDA 97

pharmaphorum

DECEMBER 7, 2022

Source: CT assessments [Haute Autorité de Santé website]; ANSM [Agence Nationale de Sécurité du Médicament et des Produits de Santé]; CRA analysis). Pricing and market access in France operate on a dual system, under which health technology assessments (HTAs) are conducted separately from pricing negotiations. Rare diseases: a flawed system.

104

104

Omnicell

JANUARY 10, 2023

You might gain benefits such as improved functionality and efficiency for clinical employees by having a simple analysis of current use and workflows connected to medication management at the point of care (both on patient floors and in operating rooms). However, pandemic burnout and other job pressures are increasing staff turnover.

Omnicell 95

Omnicell Controlled Substances Patient Care Hospitals 95

Omnicell

JANUARY 10, 2023

Ken Perez VP, Healthcare Policy and Government Affairs Life in the United States is a series of constantly changing certainties. As our population grows and ages, so does the demand for healthcare. On top of this growth, the Great Resignation has thrown a big curveball to the healthcare industry. The BLS reports that 3.8

Hospitals 98

Hospitals Patient Care 98

IDStewardship

NOVEMBER 26, 2023

1 For this reason, use of extended infusion over 3 to 4 hours or continuous infusion strategies can be ideal. Historically, therapeutic drug monitoring (TDM) has been widely utilized for vancomycin and aminoglycosides given the narrow therapeutic index. A chest CT shows multilobar pneumonia. S erum creatinine on admission : 0.42

Nursing Homes 237

Nursing Homes Hospitals Dosage 237

Omnicell

SEPTEMBER 5, 2022

Put simply: It’s imperative to have interoperability across your pharmacy systems, providing a view of inventory and medication journey to help streamline workflows, achieve closed-loop reporting, reduce medication errors, limit diversion risks, lower costs, and improve patient care. Although $9.9 billion on drug diversion.

Controlled Substances 98

Controlled Substances Omnicell Patient Care Hospitals 98

Omnicell

JANUARY 10, 2023

Carol Kimura VP, Brand, Digital, and Growth Marketing, Omnicell After 18 tumultuous months, we’re excited to finally return to our first live event! The 2019 HIMSS U.S. In fact, the top seven ranked priorities were in some way related or solvable with clinical technology and data. billion dollars.

Omnicell 98

Omnicell Patient Care 98

Omnicell

JANUARY 10, 2023

This case for automation is supported by root cause analysis (RCA) and failure modes and effects analysis (FMEA) efforts regarding sterile compounding. This case for automation is supported by root cause analysis (RCA) and failure modes and effects analysis (FMEA) efforts regarding sterile compounding.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Hospitals 52

Hospital Pharmacy Europe

MARCH 1, 2023

More recently, the US Preventative Services Task Force has endorsed this view especially for primary prevention in adults aged between 40 and 59 with a 10% or higher, 10-year risk of CVD. In 2019, US guidance suggested that aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit.

Hospitals 95

Hospitals 95

IDStewardship

JUNE 5, 2023

Gauthier, Pharm.D., BCPS, BCIDP Article posted 6 June 2023 Antimicrobial resistance (AMR) has emerged as a global healthcare crisis, threatening our ability to effectively treat infections and safeguard public health. Our expert brings a wealth of knowledge and practical experience in the realm of antimicrobial stewardship.

Vaccines 234

Vaccines Hospitals Patient Care 234

Omnicell

JANUARY 10, 2023

Disclaimer The views and opinions expressed in this blog are those of the authors. Assumptions made in the analysis do not reflect the position of any entity other than the author(s). Bethany Donato Director, Product Marketing On November 1, the U.S. Sterile compounding is one of the most labor-intensive and risky areas of pharmacy.

Sterile Compounds 98

Sterile Compounds Compounding Omnicell Patient Care 98

pharmaphorum

AUGUST 4, 2020

A new analysis from consulting firm CRA has honed in on the different challenges faced in four European markets – England, France, Germany and Scotland – and looked at how manufacturers can increase the chances of a successful appraisal. Source: CRA Analysis. Rates of approval.

Labelling 121

Labelling 121

Omnicell

JANUARY 10, 2023

We've missed connecting with our pharmacy and healthcare colleagues in person, and can't wait to share the new technology, insights, and services that are addressing the biggest challenges in medication management. If you'll be In Las Vegas, we hope you'll consider spending some time with us. ASHP Midyear is more than a meeting.

Specialty Pharmacies 89

Specialty Pharmacies Sterile Compounds Omnicell Compounding 89

pharmaphorum

JANUARY 24, 2022

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. IBM said it “remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT.”

Cerner 110

Cerner 110

Omnicell

JANUARY 10, 2023

Viewing inventory in real-time, we've seen a substantial financial benefit down to the cabinet-level. Chris Newman, PharmD, MSHA, Vice President of Clinical Services Andrea Jarzyniecki, PharmD, Director of Pharmacy Archbold Medical Center Archbold Medical Center is a thriving health system serving South Georgia and North Florida.

Omnicell 52

Omnicell Nursing Homes Patient Care Hospitals 52

European Pharmaceutical Review

MARCH 12, 2024

Traditionally, the optimisation of pharmaceutical processes is often based on empirical analysis. An alternative approach is the application of modern computational simulation tools” Traditionally, the optimisation of pharmaceutical processes is often based on empirical analysis.

Dosage 86

Dosage 86

pharmaphorum

DECEMBER 17, 2021

pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Digital health: making medicine more human. Driving transformation and innovation in healthcare.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Omnicell

JANUARY 10, 2023

Michael Korthuis Vice President of Engineering, Omnicell The changing nature of healthcare and the shift toward value-based care has led to a growing focus on better cost management while improving care. Intelligence is foundational to establishing an Autonomous Pharmacy. Connected data is crucial.

Omnicell 98

Omnicell Compounding Hospitals 98

Omnicell

JANUARY 12, 2023

Disclaimer The views and opinions expressed in this blog are those of the authors. Assumptions made in the analysis do not reflect the position of any entity other than the author(s). Assumptions made in the analysis do not reflect the position of any entity other than the author(s). Subscribe today.

Omnicell 84

Omnicell Controlled Substances Hospitals Patient Care 84

Omnicell

JANUARY 10, 2023

Join us to learn more about how you can use this free strategic tool as a framework for analysis to uncover the meaningful insights and actionable data necessary to create your own personalized path to the fully Autonomous Pharmacy. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s).

Omnicell 52

Omnicell Patient Care 52

Omnicell

JANUARY 10, 2023

Simplifying medication retrieval allows nurses to focus on the patient, not the technology. By working collaboratively, solutions were developed that fit the needs of various healthcare groups. By working collaboratively, solutions were developed that fit the needs of various healthcare groups.

Omnicell 98

Omnicell Cerner Medication Dispensing Documentation 98

Omnicell

MARCH 27, 2023

The richness of cloud-based data allows doctors, nurses, and pharmacists to view lab results or consult on medication notes, improving collaboration between healthcare teams regarding treatment plans that can now happen securely with a single click. Michael Korthuis VP of Engineering, Omnicell Data intelligence is nothing new to healthcare.

Omnicell 52

Omnicell Patient Care Hospitals 52

Omnicell

JANUARY 10, 2023

Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. Total prescription drug spend in the US was $576.9 billion in 2021 and is anticipated to increase another 6 percent this year.

Sterile Compounds 97

Sterile Compounds Omnicell Compounding Hospitals 97

Omnicell

JANUARY 10, 2023

Saint Luke's Health System is an example of a comprehensive technology strategy improving their pharmacy operations and enhancing patient care. The Kansas City, Mo., health system monitored 150 drug shortages each week and actively counted 30 to 40 critical medications at a time.

Omnicell 96

Omnicell Hospitals Communication Patient Care 96

Omnicell

JANUARY 10, 2023

Julie O'Brien Director, Product Marketing, Customer Experience, Omnicell The healthcare system is struggling to find a way forward as it works its way through yet another wave of COVID-19. Hospitals are overwhelmed and severely understaffed. As a result, clinicians have been exiting in record numbers. The current situation is not temporary.

Omnicell 98

Omnicell Hospitals 98

pharmaphorum

AUGUST 19, 2021

The Good Clinical Trials Collaborative (GCTC) has published a draft guidance document, and is asking for the life sciences sector to make its views known. A common set of standards for randomised clinical trials (RCTs) aims to help researchers develop the drugs and interventions of the future – no matter what they do or where they are based.

Documentation 105

Documentation Communication 105